comparemela.com

Latest Breaking News On - China medical system holdings limited - Page 5 : comparemela.com

CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA

Sun Pharma specialty drug Tildrakizumab makes it to China s reimbursement list

The inclusion of tildrakizumab injection in NRDL will further boost Sun Pharma commercialisation efforts globally. NRDL is a list of drugs fully or partially reimbursed by the national basic health insurance in China covering 96% of the population or more than 1.36 billion people.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.